US Continuous Positive Airway Pressure Devices Market Size, Share and Report Analysis 2035
According to Payal Rabde, who specializes in targeted therapies, HER2-targeted therapies, and precision oncology, biomarker-based diagnostics, with 4+ years of experience in market research and industry analysis, extensive research indicates strong growth opportunities in the U.S. continuous positive airway pressure devices market. The global U.S. continuous positive airway pressure devices market size was estimated at USD 1.06 billion in 2025 and is predicted to increase from USD 1.12 billion in 2026 to approximately USD 1.81 billion by 2035, expanding at a CAGR of 5.48% from 2026 to 2035. Her analysis highlights the increasing adoption of precision oncology therapies, antibody-drug conjugates, companion diagnostics, liquid biopsy, combination treatment, and AI-assisted oncology. The research also examines the competitive strategies of key industry participants, including, ResMed, Fisher & Paykel Healthcare, BMC Medical Co., Ltd, Bres Medical, Welllell, Transcend Inc. and Koninklijke Philips N.V., shaping the future by expanding personalized oncology approaches, advancing next-generation targeted therapeutics, accelerating AI-driven drug discovery combinations, real-world evidence integration, and enhancing invasive disease monitoring in the global the U.S. continuous positive airway pressure devices market.
Last Updated : 22 July 2026
Category: Medical Devices
Insight Code: 6990
Format: PDF / PPT / Excel